Linked videos:
• Bryan Johnson's magica...
• Bryan Johnson's ultima...
• New evidence shows fin...
• Finasteride will help ...
• Why Bryan Johnson shou...
• DHT is a trash hormone...
Studies:
1. Souverein PC, Herings RMC, Man in ’t Veld AJ, de la Rosette JJMCH, Farmer RDT, Leufkens HGM. Study of the association between ischemic heart disease and use of alpha-blockers and finasteride indicated for the treatment of benign prostatic hyperplasia. Eur Urol. 2002;42(3):254-261. doi:10.1016/s0302-2838(02)00273-7
2. Lösel R, Wehling M. Nongenomic actions of steroid hormones. Nat Rev Mol Cell Biol. 2003;4(1):46-55. doi:10.1038/nrm1009
3. Clark RV, Hermann DJ, Cunningham GR, Wilson TH, Morrill BB, Hobbs S. Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor. The Journal of Clinical Endocrinology & Metabolism. 2004;89(5):2179-2184. doi:10.1210/jc.2003-030330
4. O’Keefe JH, Cordain L, Harris WH, Moe RM, Vogel R. Optimal low-density lipoprotein is 50 to 70 mg/dl: Lower is better and physiologically normal. Journal of the American College of Cardiology. 2004;43(11):2142-2146. doi:10.1016/j.jacc.2004.03.046
5. Andriole GL, Bostwick DG, Brawley OW, et al. Effect of Dutasteride on the Risk of Prostate Cancer. New England Journal of Medicine. 2010;362(13):1192-1202. doi:10.1056/NEJMoa0908127
6. Schmidt LJ, Tindall DJ. Steroid 5 α-reductase inhibitors targeting BPH and prostate cancer. The Journal of Steroid Biochemistry and Molecular Biology. 2011;125(1-2):32-38. doi:10.1016/j.jsbmb.2010.09.003
7. Loke YK, Ho R, Smith M, et al. Systematic review evaluating cardiovascular events of the 5-alpha reductase inhibitor - Dutasteride. J Clin Pharm Ther. 2013;38(5):405-415. doi:10.1111/jcpt.12080
8. Rubio-Gayosso I, Ramirez-Sanchez I, Ita-Islas I, et al. Testosterone metabolites mediate its effects on myocardial damage induced by ischemia/reperfusion in male Wistar rats. Steroids. 2013;78(3):362-369. doi:10.1016/j.steroids.2012.12.004
9. Kim J, McEvoy JW, Nasir K, et al. Critical Review of High-Sensitivity C-Reactive Protein and Coronary Artery Calcium for the Guidance of Statin Allocation. Circulation: Cardiovascular Quality and Outcomes. 2014;7(2):315-322. doi:10.1161/CIRCOUTCOMES.113.000519
10. Zwadlo C, Schmidtmann E, Szaroszyk M, et al. Antiandrogenic Therapy With Finasteride Attenuates Cardiac Hypertrophy and Left Ventricular Dysfunction. Circulation. 2015;131(12):1071-1081. doi:10.1161/CIRCULATIONAHA.114.012066
11. Froese N, Wang H, Zwadlo C, et al. Anti-androgenic therapy with finasteride improves cardiac function, attenuates remodeling and reverts pathologic gene-expression after myocardial infarction in mice. Journal of Molecular and Cellular Cardiology. 2018;122:114-124. doi:10.1016/j.yjmcc.2018.08.011
12. Chang J, Choi S, Kim K, Park SM. Cardiovascular Safety and Possible Benefit of a 5-Alpha Reductase Inhibitor among Benign Prostatic Hyperplasia Patients, A Nationally Representative Cohort of Korean Men. J Clin Med. 2019;8(5):733. doi:10.3390/jcm8050733
13. Kattih B, Elling LS, Weiss C, et al. Anti-androgenic therapy with finasteride in patients with chronic heart failure - a retrospective propensity score based analysis. Sci Rep. 2019;9(1):10139. doi:10.1038/s41598-019-46640-8
14. Maldonado O, Ramos A, Guapillo M, et al. Effects of chronic inhibition of Testosterone metabolism on cardiac remodeling after ischemia/reperfusion-induced myocardial damage in gonadectomized rats. Biol Open. 2019;8(5):bio041905. doi:10.1242/bio.041905
15. Mata EFD, Nascimento AM do, Lima EM de, et al. Finasteride promotes worsening of the cardiac deleterious effects of nandrolone decanoate and protects against genotoxic and cytotoxic damage. Braz J Pharm Sci. 2020;56. doi:10.1590/s2175-97902019000318289
16. Lusty A, Siemens DR, Tohidi M, Whitehead M, Tranmer J, Nickel JC. Cardiac Failure Associated with Medical Therapy of Benign Prostatic Hyperplasia: A Population Based Study. Journal of Urology. 2021;205(5):1430-1437. doi:10.1097/JU.0000000000001561
17. Ayele HT, Reynier P, Azoulay L, Platt RW, Benayoun S, Filion KB. The Cardiovascular Safety of Five-Alpha-Reductase Inhibitors Among Men with Benign Prostatic Hyperplasia: A Population-Based Cohort Study. The American Journal of Medicine. 2023;136(10):1000-1010.e7. doi:10.1016/j.amjmed.2023.06.021
18. McQueen P, Molina D, Pinos I, et al. Finasteride delays atherosclerosis progression in mice and is associated with a reduction in plasma cholesterol in men. Journal of Lipid Research. 2024;65(3). doi:10.1016/j.jlr.2024.100507
Негізгі бет Тәжірибелік нұсқаулар және стиль New evidence proves finasteride protects your heart and can prolong your life
Пікірлер: 481